- Home
- NRT vs NVNO Comparison
NRT vs NVNO Comparison
Compare NRT & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRT
- NVNO
- Stock Information
- Founded
- NRT 1975
- NVNO 1987
- Country
- NRT United States
- NVNO United States
- Employees
- NRT N/A
- NVNO N/A
- Industry
- NRT Oil & Gas Production
- NVNO Medical/Dental Instruments
- Sector
- NRT Energy
- NVNO Health Care
- Exchange
- NRT Nasdaq
- NVNO Nasdaq
- Market Cap
- NRT 40.5M
- NVNO 41.0M
- IPO Year
- NRT N/A
- NVNO N/A
- Fundamental
- Price
- NRT $4.90
- NVNO $3.65
- Analyst Decision
- NRT
- NVNO
- Analyst Count
- NRT 0
- NVNO 0
- Target Price
- NRT N/A
- NVNO N/A
- AVG Volume (30 Days)
- NRT 24.4K
- NVNO 76.7K
- Earning Date
- NRT 05-30-2025
- NVNO 05-01-2025
- Dividend Yield
- NRT 9.74%
- NVNO N/A
- EPS Growth
- NRT N/A
- NVNO N/A
- EPS
- NRT 0.56
- NVNO N/A
- Revenue
- NRT $5,942,748.00
- NVNO N/A
- Revenue This Year
- NRT N/A
- NVNO N/A
- Revenue Next Year
- NRT N/A
- NVNO $409.09
- P/E Ratio
- NRT $8.44
- NVNO N/A
- Revenue Growth
- NRT N/A
- NVNO N/A
- 52 Week Low
- NRT $3.88
- NVNO $2.03
- 52 Week High
- NRT $8.48
- NVNO $6.48
- Technical
- Relative Strength Index (RSI)
- NRT 64.87
- NVNO 71.64
- Support Level
- NRT $4.51
- NVNO $2.61
- Resistance Level
- NRT $4.84
- NVNO $3.97
- Average True Range (ATR)
- NRT 0.18
- NVNO 0.22
- MACD
- NRT 0.05
- NVNO 0.11
- Stochastic Oscillator
- NRT 100.00
- NVNO 80.00
About NRT North European Oil Royality Trust
North European Oil Royalty Trust holds overriding royalty rights covering gas and oil production in certain concessions or leases in the Federal Republic of Germany. The properties of the trust are overriding royalty rights on sales of gas, sulfur, and oil under certain concessions or leases in the Federal Republic of Germany. The trust also holds other royalty rights, which are based on leases. It receives various percentages of royalties on the proceeds of the sales of certain products from the areas involved.
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.